Related Experiment Video
Updated: Sep 2, 2025
Light-sheet Microscopy for Three-dimensional Visualization of Human Immune Cells
Published on: June 13, 2018
A Landscape Study on COVID-19 Immunity at the Single-Cell Level
Rongguo Wei1,2,3, Zheng Qin3,4, Qi Huang3,4
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Biosafety Mega-Science, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Insights
This study reveals how immune cell disorders at the single-cell level contribute to COVID-19 pathogenesis. Key findings show altered macrophage, T cell, and NK cell proportions and inflammation pathway involvement in severe COVID-19.
Area of Science:
- Immunology
- Cell Biology
- Infectious Diseases
Background:
- The ongoing COVID-19 pandemic necessitates understanding its pathogenesis at a granular level.
- Disruptions in cellular function and immune responses are implicated in severe COVID-19 outcomes.
- The specific roles of individual cell types and molecular pathways in COVID-19 pathogenesis remain incompletely understood.
Purpose of the Study:
- To investigate single-cell level disorders in macrophages, epithelial cells, CD8+ T cells, and NK cells during COVID-19.
- To analyze the immune response, particularly concerning cytokine storm, at the single-cell level.
- To identify specific cellular pathways involved in COVID-19 pathogenesis and immune dysregulation.
Main Methods:
- Single-cell analysis of immune cells (macrophages, T cells, NK cells) and epithelial cells in COVID-19 patients.
- Comparative analysis between healthy individuals and patients with varying COVID-19 severity.
- Exploration of gene expression and pathway enrichment, including inflammatory signaling pathways.
Main Results:
- COVID-19 patients exhibited altered proportions of macrophages (increased) and T/NK cells (decreased) compared to healthy controls.
- Macrophage and epithelial cell proportions increased with disease severity from mild to severe.
- Elevated pro-inflammatory and chemokine expressions were observed; specific cell subsets were linked to IL-17 and TNF signaling pathways.
Conclusions:
- Single-cell analysis provides critical insights into COVID-19 immune response and pathogenesis.
- Abnormal functions of specific macrophage, epithelial, CD8+ T, and NK cell subsets are implicated in COVID-19.
- Understanding these cellular and pathway alterations offers a new perspective for therapeutic strategies against COVID-19.
Abstract:
Since 2019, the coronavirus (COVID-19) has outbroken continuously, spreading internationally and threatening the public health. However, it was unknown how the disorder at the single-cell level was associated with the pathogenesis of COVID-19. This study presented the disorders of macrophages, epithelial cells, CD8+ T cells, and natural killer (NK) cells at the single-cell level in the courses of COVID-19 and analyzed the immune response to cytokine storm. Compared with the healthy group, patients with COVID-19 had higher proportions of macrophages and lower proportions of T and NK cells, especially proportions of macrophages and epithelial cells with an increase during patients' conditions from mild to severe. This study suggested that there were high levels of pro-inflammatory and chemokine expressions in cells of COVID-19 and analyzed cell subsets to explore its changes and pathways. It was worth noting that several subsets of macrophages, epithelial cells, CD8 T cells, and NK cells were involved in inflammation pathways, including interleukin-17 (IL-17) signaling pathway and tumor necrosis factor (TNF) signaling pathway. Moreover, the pathways interacting COVID-19 and cytokine receptor with each other were remarkably enriched. In addition, these cell subsets played important roles in inflammation, and their abnormal functions may cause COVID-19. In conclusion, this study provided an immune outlook for COVID-19 at the single-cell level and revealed different pathways in immune response of COVID-19 single cells.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:23Cells of the Adaptive Immune Response